Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, 2 days ago

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, 3 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
6 days ago
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.

Frailty significantly predicts overactive bladder

03 Jun 2017

Older patients with overactive bladder (OAB) appear to have increased frailty compared with individuals seeking care for other nononcologic urologic diagnosis, with frailty being a significant predictor of OAB, a study has found.

The prospective study included 201 OAB patients and 1,162 non-OAB individuals aged ≥65 years. All patients underwent a timed up-and-go test (TUGT), a measure of frailty, and were thereby categorized according to the results: fast (≤10 seconds), intermediate (11 to 14 seconds) and slow (≥15 seconds).

Logistic regression analysis was performed to examine the relationship between frailty and OAB. Adjustments for age, gender and race were made.

Results revealed that patients with OAB were significantly slower in the execution of TUGT compared with controls (13.7 vs 10.9 seconds; p<0.0001), with the proportion of individuals categorized as slow or frail being higher in the OAB group (32.3 vs 11.0 percent).

On multivariable analysis, slower TUGT was a significant predictor of OAB (adjusted odds ratio [OR], 3.0; 95 percent CI, 2.0 to 4.8). Age showed no independent association with the urologic condition (p>0.05).

The findings suggest that OAB patients aged ≥65 years are significantly frailer than individuals without the condition, and that frailty significantly predicts OAB. In light of the data, “frailty should be considered when caring for older patients with OAB, and OAB should be assessed when caring for frail older patients,” researchers said.

OAB is characterized by urinary frequency, nocturia and urgency with or without incontinence. In older adults, urinary incontinence and lower urinary tract symptoms are highly prevalent and are strongly associated with frailty. [LUTS 2012;4:48–55]

Frailty as a concept has been defined as “the accumulation of impairments” and as a phenotypic model. As a phenotype, frailty is said to be a biologic syndrome of decreased reserve and resistance to stressors, as a result of cumulative declines across multiple physiologic systems and causing vulnerability to adverse outcomes. By either definition, greater frailty is strongly linked to elevated mortality and risk of institutionalization. [Clin Pract 2014;11:431–440]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, 2 days ago

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, 3 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
6 days ago
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.